Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of MTERF mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of MTERF mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MTERF mRNA | affects expression | 16483693
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of MTERF mRNA | affects cotreatment|decreases expression | 20360939
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of MTERF mRNA | decreases expression | 20106945
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of MTERF mRNA | affects cotreatment|decreases expression | 20360939
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.02 | 18287403 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
3.01 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
4.36 | 16434500 19061943 17162532 19052882 18056438 17620307 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.20 | 17474063 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.80 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.80 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
4.80 | 16878318 18393292 3084413 19335982 17055752 17428255 18788625 18691550 17173139 16830150 10737359 16681979 20214788 18056438 16569478 20007298 19052882 20524982 19171122 20084675 17978847 18978308 19701751 17162532 18506893 16698587 20514400 20101231 17761372 19519916 19539802 19383236 19919837 19107877 16288022 20512989 20727157 19394651 10672840 18785209 18210153 19822196 19208518 16807293 17138121 16540662 16502159 3581430 18665156 21159647 16935385 18494052 16328049 20432363 18971187 11831363 19418558 20935162 16779866 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
12.39 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
12.39 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
12.39 | 17174075 2727394 7505956 21159647 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.97 | 19052882 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.14 | 19486331 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
12.32 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
12.32 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.25 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.69 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.69 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.69 | 19107877 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.64 | 16302075 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.82 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
8.82 | 20387270 21071580 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.56 | 12168785 12639820 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.68 | 8708960 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.88 | 15720958 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.19 | 10903974 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.52 | 18785209 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.89 | 10783313 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.96 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
6.84 | 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.84 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
13.97 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
13.97 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.97 | 12371664 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
4.18 | 16766008 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.98 | 20032147 19638242 18665156 18407596 18522880 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.16 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.89 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
4.89 | 16942905 18977376 20501860 2862719 20452335 12112319 19427195 12771043 20492335 20137499 19256749 15175105 19996281 18644402 20434301 21071580 15885732 21278145 19255062 20101389 19812893 19690152 19833225 19254457 9163691 19294768 20118626 18648771 18978307 19499222 20583210 18754104 19850985 19642983 21167192 19426721 10737359 19638242 21047994 19090486 20405173 2422723 19073162 19551842 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.54 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
6.54 | 18079962 18775883 18544905 2563599 18164116 19539802 18093689 16267830 18253720 19519916 19004024 9362446 16842330 19009564 18282651 17174075 19126423 18308698 17854601 21159647 17942915 3124819 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
1.76 | 6695378 20970405 21163286 20512841 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.31 | 16801185 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.94 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.94 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.67 | 9029167 3581430 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.96 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.57 | 18481113 19348381 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.61 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.64 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.92 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.92 | 16049721 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.51 | 16540662 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.91 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.91 | 2563599 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.31 | 16882103 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.56 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.56 | 18551238 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.22 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.36 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.36 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
13.58 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
13.58 | 10091137 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.50 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.96 | 17120751 |